Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
  1. 2019
  2. E-pub ahead of print

    Patients' views on routine collection of patient-reported outcomes in rheumatology outpatient care - a multicenter focus group study

    Primdahl, J., Jensen, D. V., Meincke, R. H., Jensen, K. V., Ziegler, C., Nielsen, S. W., Dalsgaard, L., Kildemand, M., Hetland, M. L. & Esbensen, B. A., 29 Jun 2019, In : Arthritis Care & Research.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published
  4. E-pub ahead of print

    Response to: 'Mandatory, cost-driven switching from originator etanercept to its biosimilar SB4: possible fallout on non-medical switching' by Cantini and Benucci

    Glintborg, B., Loft, A. G., Omerovic, E., Hendricks, O., Linauskas, A., Espesen, J., Danebod, K., Jensen, D. V., Nordin, H., Dalgaard, E. B., Chrysidis, S., Kristensen, S., Raun, J. L., Lindegaard, H., Manilo, N., Jakobsen, S. H., Hansen, I. M. J., Dalsgaard Pedersen, D., Sørensen, I. J., Andersen, L. S., Grydehøj, J., Mehnert, F., Krogh, N. S. & Hetland, M. L., 2019, In : Annals of the Rheumatic Diseases.

    Research output: Contribution to journalComment/debateResearchpeer-review

  5. Published

    To switch or not to switch: results of a nationwide guideline of mandatory switching from originator to biosimilar etanercept. One-year treatment outcomes in 2061 patients with inflammatory arthritis from the DANBIO registry

    Glintborg, B., Loft, A. G., Omerovic, E., Hendricks, O., Linauskas, A., Espesen, J., Danebod, K., Jensen, D. V., Nordin, H., Dalgaard, E. B., Chrysidis, S., Kristensen, S., Raun, J. L., Lindegaard, H., Manilo, N., Jakobsen, S. H., Hansen, I. M. J., Dalsgaard Pedersen, D., Sørensen, I. J., Andersen, L. S., Grydehøj, J., Mehnert, F., Krogh, N. S. & Hetland, M. L., 2019, In : Annals of the Rheumatic Diseases. 78, 2

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. 2018
  7. Published

    Drug concentrations and anti-drug antibodies during treatment with biosimilar infliximab (CT-P13) in routine care

    Glintborg, B., Kringelbach, T., Bolstad, N., Warren, D. J., Eng, G., Sørensen, I. J., Loft, A. G., Hendricks, O., Hansen, I., Linauskas, A., Nordin, H., Kristensen, S., Lindegaard, H., Jensen, D. V., Goll, G. L., Høgdall, E., Gehin, J., Enevold, C., Nielsen, C. H., Krogh, N. S., Johansen, J. S. & Hetland, M. L., Sep 2018, In : Scandinavian Journal of Rheumatology. 47, 5, p. 418-421 4 p.

    Research output: Contribution to journalLetterResearchpeer-review

  8. Published
  9. Published
  10. Published

    Dose tapering and discontinuation of biological therapy in rheumatoid arthritis patients in remission in routine care – 2-year outcomes and identification of predictors

    Brahe, C. C. H., Krabbe, S., Østergaard, M., Ørnbjerg, L. M., Glinatsi, D. E., Røgind, H., Jensen, H. S., Hansen, A., Nørregaard, J., Jacobsen, S., Terslev, L., Huynh, T. K., Jensen, D. V., Manilo, N., Asmussen, K., Frandsen, P. B., Boesen, M., Rastiemadabadi, Z., Morsel-Carlsen, L., Møller, J. M., Krogh, N. S. & Hetland, M. L., 2018, In : Annals of the Rheumatic Diseases. 77, Suppl. 2, p. 70-1 2 p., OP0038.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  11. Published
  12. Published

    One-year follow-up of a nationwide cohort of patients with inflammatory arthritis, who switched from originator to biosimilar etanercept, focusing on patients who switched back to originator. An observational Danbio study

    Glintborg, B., Sørensen, I. J., Omerovic, E., Mehnert, F., Manilo, N., Danebod, K., Jensen, D. V., Nordin, H., Loft, A. G., Hendricks, O., Chrysidis, S., Andersen, B. L., Raun, J. L., Lindegaard, H., Espesen, J., Jakobsen, S. H., Hansen, I. M. J., Dalsgaard, E. B., Pedersen, D. D., Kristensen, S., Linauskas, A., Andersen, L. S., Grydehøj, J., Krogh, N. S. & Hetland, M. L., 2018, In : Annals of the Rheumatic Diseases. 77, Suppl. 2, p. 595-6 2 p., FRI0103.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  13. Published

    One-year follow-up of a nationwide cohort of patients with inflammatory arthritis, who switched from originator to biosimilar etanercept, focusing on patients who switched back to originator: An observational DANBIO study

    Glintborg, B., Sørensen, I. J., Omerovic, E., Mehnert, F., Manilo, N., Danebod, K., Jensen, D. V., Nordin, H., Hendricks, O., Loft, A. G., Chrysidis, S., Andersen, B. L., Raun, J. L., Lindegaard, H., Espesen, J., Jakobsen, S. H., Hansen, I. J., Dalgaard, E. B., Pedersen, D. D., Kristensen, S., Linauskas, A., Andersen, L. S., Grydehøj, J., Krogh, N. S. & Hetland, M. L., 2018, In : Scandinavian Journal of Rheumatology, Supplement. 47, Suppl. 129, p. 56-7 2 p., PP66.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  14. Published

    One-year treatment retention after a nationwide non-medical switch from originator to biosimilar etanercept in 2,061 patients with inflammatory arthritis followed in the Danbio registry

    Glintborg, B., Sørensen, I. J., Omerovic, E., Mehnert, F., Manilo, N., Danebod, K., Jensen, D. V., Nordin, H., Loft, A. G., Hendricks, O., Chrysidis, S., Andersen, B. L., Raun, J. L., Lindegaard, H., Espesen, J., Jakobsen, S. H., Hansen, I. M. J., Dalsgaard, E. B., Pedersen, D. D., Kristensen, S., Linauskas, A., Andersen, L. S., Grydehøj, J., Krogh, N. & Hetland, M. L., 2018, In : Annals of the Rheumatic Diseases. 77, Suppl. 2, p. 313-4 2 p., THU0189.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  15. Published

    One-year treatment retention after a nationwide nonmedical switch from originator to biosimilar etanercept in 2061 patients with inflammatory arthritis followed in the DANBIO registry

    Glintborg, B., Sørensen, I. J., Omerovic, E., Mehnert, F., Manilo, N., Danebod, K., Jensen, D. V., Nordin, H., Hendricks, O., Loft, A. G., Chrysidis, S., Andersen, B. L., Raun, J. L., Lindegaard, H., Espesen, J., Jakobsen, S. H., Hansen, I. J., Dalgaard, E. B., Pedersen, D. D., Kristensen, S., Linauskas, A., Andersen, L. S., Grydehøj, J., Krogh, N. S. & Hetland, M. L., 2018, In : Scandinavian Journal of Rheumatology, Supplement. 47, Suppl. 129, p. 57-8 2 p., PP67.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  16. Published

    Patients’ views on routine collection of patient-reported outcomes in rheumatology care – A Danbio focus group study

    Primdahl, J., Jensen, D. V., H. Meincke, R., Jensen, K. V., Ziegler, C., Nielsen, S. W., Dalsgaard, L., Kildemand, M., Hetland, M. L. & Esbensen, B. A., 2018, In : Annals of the Rheumatic Diseases. 77, Suppl. 2, p. 210 1 p., OP0328-HPR.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  17. Published
  18. 2017
  19. Published

    A nationwide non-medical switch from originator infliximab to biosimilar CT-P13 in 802 patients with inflammatory arthritis: 1-year clinical outcomes from the DANBIO registry

    Glintborg, B., Sørensen, I. J., Loft, A. G., Lindegaard, H., Linauskas, A., Hendricks, O., Hansen, I. M. J., Jensen, D. V., Manilo, N., Espesen, J., Klarlund, M., Grydehøj, J., Dieperink, S. S., Kristensen, S., Olsen, J. S., Nordin, H., Chrysidis, S., Dalsgaard Pedersen, D., Sørensen, M. V., Andersen, L. S., Grøn, K. L., Krogh, N. S., Pedersen, L., Hetland, M. L. & all departments of rheumatology in Denmark, Aug 2017, In : Annals of the Rheumatic Diseases. 76, 8, p. 1426-1431 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  20. Published
  21. Published
  22. Published

    Clinical outcomes from a nationwide non-medical switch from originator to biosimilar etanercept in patients with inflammatory arthritis after 5 months follow-up. results from the danbio registry

    Glintborg, B., Sørensen, I. J., Loft, A. G., Esbesen, J., Lindegaard, H., Jensen, D. V., Danebod, K., Dieperink, S. S., Hendricks, O., Hansen, I. M. J., Linauskas, A., Kristensen, S., Andersen, L. S., Hossein, M., Nordin, H., Andersen, B. L., Chrysidis, S., Raun, J. L., Manillo, N., Grydehøj, J., Dalgaard, E. B., Pedersen, D. D., Krogh, N. S. & Hetland, M. L., 2017, In : Annals of the Rheumatic Diseases. 76, Suppl 2, p. 553-554 2 p.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  23. Published
  24. Published

    DANBIO National Årsrapport 2016

    Jensen, D. V. & Hetland, M. L., 2017, Eget Forlag. 126 p.

    Research output: Book/ReportReportResearchpeer-review

  25. Published

    One-Year Clinical Outcomes in 1623 Patients with Inflammatory Arthritis Who Switched from Originator to Biosimilar Etanercept – an Observational Study from the Danish Danbio Registry

    Glintborg, B., Omerovic, E., Danebod, K., Jensen, D. V., Nordin, H., Loft, A. G., Chrysidis, S., Raun, J. L., Hendricks, O., Lindegaard, H., Espesen, J., Jakobsen, S., Hansen, I. M. J., Grydehøj, J., Dalgaard, E., Pedersen, D. D., Manilo, N., Andersen, L. S., Kristensen, S., Linauskas, A., Krogh, N. S. & Hetland, M. L., 2017, In : Arthritis & Rheumatology. 69, S10, 1550.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  26. Published

    Validity and completeness of rheumatoid arthritis diagnoses in the nationwide DANBIO clinical register and the Danish National Patient Registry

    Ibfelt, E. H., Sørensen, J., Jensen, D. V., Dreyer, L., Schiøttz-Christensen, B., Thygesen, P. H., Colic, A., Raun, J. L., Manilo, N., Rødgaard, A., Poulsen, U. E., Rasmussen, C., Hansen, T., Unger, B., Pelck, R., Kincses, A., Nordin, H., Lorenzen, T., Theibich, A., Jensen Hansen, I. M., Espesen, J., Grydehøj, J., Holland-Fischer, M., Loft, A. G. & Hetland, M. L., 2017, In : Clinical Epidemiology. 9, p. 627-632 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  27. 2016
  28. Published

    Using an electronic platform interactively to improve treatment outcome in patients with rheumatoid arthritis: new developments from the DANBIO registry

    Hetland, M. L., Krogh, N. S., Hørslev-Petersen, K., Schiøttz-Christensen, B., Sørensen, I. J. & Jensen, D. V., 21 Oct 2016, In : Clinical and Experimental Rheumatology. 34, 5 Suppl 101, p. S75-8 4 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  29. Published

    A Nationwide Non-Medical Switch from Originator to Biosimilar Infliximab in Patients with Inflammatory Arthritis. Eleven Months’ Clinical Outcomes from the Danbio Registry

    Glintborg, B., Sørensen, I. J., Jensen, D. V., Krogh, N. S., Loft, A. G., Espesen, J., Olsen, J., Hendricks, O., Grydehøj, J., Hansen, I. M. J., Sørensen, M. V., Chrysidis, S., Andersen, B. L., Manilo, N., Klarlund, M., Andersen, L. S., Nordin, H., Kristensen, S., Nørregaard, J. & Hetland, M. L., 2016, In : Arthritis & Rheumatology. 68, S10, 951.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  30. Published

    DANBIO National Årsrapport 2015

    Jensen, D. V. & Hetland, M. L., 2016, Eget Forlag. 129 p.

    Research output: Book/ReportReportResearchpeer-review

  31. Published
  32. Published
  33. Published

    Non-Medical Switch from Originator To Biosimilar Infliximab among Patients with Inflammatory Rheumatic Disease – Impact on S-Infliximab and Antidrug-Antibodies. Results from The National Danish Rheumatologic Biobank and The Danbio Registry

    Glintborg, B., Kringelbach, T. M., Høgdall, E., Sørensen, I. J., Jensen, D. V., Loft, A. G., Hendricks, O., Jensen Hansen, I. M., Bolstad, N., Grøn, K. L., Eng, G., Enevold, C., Nielsen, C. H., Warren, D., Goll, G., Gehin, J., Johansen, J. S. & Hetland, M. L., 2016, In : Annals of the Rheumatic Diseases. 75, Suppl. 2, p. 224 1 p., THU0123.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  34. Published

    Non-Medical Switch from Originator to Biosimilar Infliximab in Patients with Inflammatory Arthritis – Impact on s-Infliximab and Antidrug-Antibodies. Results from the Danish Rheumatologic Biobank and the Danbio Registry

    Glintborg, B., Kringelbach, T. M., Høgdall, E., Sørensen, I. J., Jensen, D. V., Loft, A. G., Hendricks, O., Hansen, I. M. J., Linauskas, A., Kristensen, S., Lindegaard, H., Nordin, H., Bolstad, N., Warren, D., Warren, D., Gehin, J., Goll, G. L., Grøn, K. L., Eng, G. P., Enevold, C., Nielsen, C. H., Johansen, J. S. & Hetland, M. L., 2016, In : Arthritis & Rheumatology. 68, S10, 1997.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  35. Published

    Non-medical switch from originator to biosimilar infliximab in patients with inflammatory arthritis: impact on s-infliximab and antidrug antibodies. Results from the Danish Rheumatological Biobank and the DANBIO registry

    Glintborg, B., Kringelbach, T. M., Høgdall, E., Sørensen, I. J., Jensen, D. V., Loft, A. G., Hendricks, O., Hansen, I. M. J., Bolstad, N., Warren, D. J., Gehin, J., Goll, G., Grøn, K. L., Eng, G., Enevold, C., Nielsen, C. H., Johansen, J. S. & Hetland, M. L., 2016, In : Scandinavian Journal of Rheumatology. 45, Suppl. 128, p. 6-7 2 p., OP10.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  36. Published

    The Danish nationwide clinical register for patients with rheumatoid arthritis: DANBIO

    Ibfelt, E. H., Jensen, D. V. & Hetland, M. L., 2016, In : Clinical Epidemiology. 8, p. 737-42 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  37. Published

    Three Months' Clinical Outcomes from A Nationwide Non-Medical Switch from Originator To Biosimilar Infliximab in Patients with Inflammatory Arthritis. Results from The Danbio Registry

    Glintborg, B., Sørensen, I. J., Jensen, D. V., Krogh, N. S., Loft, A. G., Colic, A., Espesen, J., Olsen, J., Hendricks, O., Grydehøj, J., Hansen, I. M. J., Sørensen, M. V., Chrysidis, S., Manilo, N., Klarlund, M., Andersen, L. S., Nordin, H., Kristensen, S. & Hetland, M. L., 2016, In : Annals of the Rheumatic Diseases. 75, Suppl. 2, p. 142 1 p., OP0225.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  38. Published

    Three months’ clinical outcomes from a nationwide non-medical switch from originator to biosimilar infliximab in patients with inflammatory arthritis. Results from the DANBIO registry

    Glintborg, B., Sørensen, I. J., Jensen, D. V., Krogh, N. S., Loft, A. G., Colic, A., Espesen, J., Olsen, J., Hendricks, O., Grydehøj, J., Hansen, I. M. J., Sørensen, M. V., Chrysidis, S., Linauskas, A., Lindegaard, H. M., Andersen, B. L., Manilo, N., Klarlund, M., Andersen, L. S., Nordin, H., Kristensen, S. & Hetland, M. L., 2016, In : Scandinavian Journal of Rheumatology. 45, Suppl. 128, p. 4-5 2 p., OP07.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  39. 2015
  40. Published

    Effectiveness and drug adherence of biologic monotherapy in routine care of patients with rheumatoid arthritis: a cohort study of patients registered in the Danish biologics registry

    Jørgensen, T. S., Kristensen, L. E., Christensen, R., Bliddal, H., Lorenzen, T., Hansen, M. S., Østergaard, M., Jensen, J., Zanjani, L., Laursen, T., Butt, S., Dam, M. Y., Lindegaard, H. M., Espesen, J., Hendricks, O., Kumar, P., Kincses, A., Larsen, L. H., Andersen, M., Næser, E., Jensen, D. V., Grydehøj, J., Unger, B., Dufour, N., Sørensen, V., Vildhøj, S., Jensen Hansen, I. M., Raun, J., Krogh, N. S. & Lund Hetland, M., Dec 2015, In : Rheumatology (Oxford, England). 54, 12, p. 2156-65 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  41. Published
  42. Published

    DANBIO National Årsrapport 2014

    Jensen, D. V. & Hetland, M. L., 2015, Eget Forlag. 96 p.

    Research output: Book/ReportReportResearchpeer-review

  43. Published

    TUMOUR NECROSIS FACTOR ALPHA INHIBITOR TREATMENT NORMALISES HAND ONE LOSS IN A MINORITY OF RHEUMATOID ARTHRITIS PATIENTS TREATED IN CLINICAL PRACTICE. RESULTS FROM THE COPENHAGEN OSTEOARTHRITIS STUDY AND THE DANBIO REGISTRY

    Ørnbjerg, L. M., Østergaard, M., Jensen, T., Hyldstrup, L., Bach-Mortensen, P., Bøyesen, P., Thormann, A., Tarp, U., Lindegaard, H., Schlemmer, A., Graudal, N., Andersen, A., Espesen, J., Kollerup, G., Glintborg, B., Madsen, O. R., Jensen, D. V. & Hetland, M. L., 2015, In : Annals of the Rheumatic Diseases. 74, Suppl. 2, p. 677 1 p.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  44. Published

    Tumour Necrosis Factor Inhibitor Treatment Normalises Hand Bone Loss in a Minority of Rheumatoid Arthritis Patients Treated in Clinical Practice. Results from the Copenhagen Osteoarthritis Study and the Danbio Registry

    Ørnbjerg, L. M., Østergaard, M., Jensen, T. D., Bach-Mortensen, P., Hyldstrup, L., Boyesen, P., Thormann, A., Tarp, U., Bøhme, W., Lindegaard, H., Poulsen, U. E., Hansen, A., Schlemmer, A., Graudal, N., Andersen, A., Espesen, J., Kollerup, G., Glintborg, B., Madsen, O. R., Jensen, D. V. & Hetland, M. L., 2015, In : Arthritis & Rheumatology. 67, S10, p. 1665-6 2 p.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  45. 2014
  46. Published

    Which factors influence radiographic progression during treatment with tumor necrosis factor inhibitors in clinical practice? Results from 930 patients with rheumatoid arthritis in the nationwide Danish DANBIO registry

    Ørnbjerg, L. M., Østergaard, M., Bøyesen, P., Krogh, N. S., Thormann, A., Tarp, U., Poulsen, U. E., Espesen, J., Schlemmer, A., Graudal, N., Kollerup, G., Jensen, D. V., Madsen, O. R., Glintborg, B., Christensen, T., Lindegaard, H., Bøhme, W., Hansen, A., Andersen, A. R. & Hetland, M. L., Dec 2014, In : Journal of Rheumatology. 41, 12, p. 2352-60 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  47. Published

    Monitoring patients with rheumatoid arthritis in routine care: experiences from a treat-to-target strategy using the DANBIO registry

    Hetland, M. L., Jensen, D. V. & Krogh, N. S., 5 Nov 2014, In : Clinical and Experimental Rheumatology. 32 Suppl 85, 5, p. 141-146 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  48. Published

    Danbio National Årsrapport 2013

    Hetland, M. L. & Jensen, D. V., 2014, GP-Tryk A/S. 94 p.

    Research output: Book/ReportReportResearchpeer-review

  49. Published

    Monitoring patients with rheumatoid arthritis in routine care – Experiences from a treat-to-target strategy using the Danbio registry.

    Hetland, M. L., Jensen, D. V. & Krogh, N. S., 2014, In : Arthritis & Rheumatology. 66, Suppl. 11, p. S804 1 p.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  50. 2013
  51. Published
  52. Published

    Clinical response, drug survival and predictors thereof in 432 ankylosing spondylitis patients after switching tumour necrosis factor α inhibitor therapy: results from the Danish nationwide DANBIO registry

    Glintborg, B., Østergaard, M., Krogh, N. S., Tarp, U., Manilo, N., Loft, A. G. R., Hansen, A., Schlemmer, A., Fana, V., Lindegaard, H. M., Nordin, H., Rasmussen, C., Ejstrup, L., Jensen, D. V., Petersen, P. M. & Hetland, M. L., 2013, In : Annals of the Rheumatic Diseases. 72, p. 1149-1155

    Research output: Contribution to journalJournal articleResearchpeer-review

  53. Published

    DANBIO Årsrapport 2012

    Jensen, D. V. & Hetland, M. L., 2013, Eget Forlag.

    Research output: Book/ReportReportResearchpeer-review

  54. Published

    Impact of tumour necrosis factor inhibitor treatment on radiographic progression in rheumatoid arthritis patients in clinical practice: results from the nationwide Danish DANBIO registry

    Ørnbjerg, L. M., Østergaard, M., Bøyesen, P., Krogh, N. S., Thormann, A., Tarp, U., Poulsen, U. E., Espesen, J., Ringsdal, V. S., Graudal, N., Kollerup, G. B., Jensen, D. V., Madsen, O. R., Glintborg, B., Christensen, T. S., Lindegaard, H. M., Dencker, D., Hansen, A., Andersen, A. R. & Hetland, M. L., 2013, In : Annals of the Rheumatic Diseases. 72, 1, p. 57-63 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  55. Published

    Incidences of overall and site specific cancers in TNFα inhibitor treated patients with rheumatoid arthritis and other arthritides - a follow-up study from the DANBIO Registry

    Dreyer, L., Mellemkjær, L., Andersen, A. R., Bennett, P., Poulsen, U. E., Juulsgaard Ellingsen, T., Hansen, T. H., Jensen, D. V., Linde, L., Lindegaard, H. M., Loft, A. G. R., Nordin, H., Omerovic, E., Rasmussen, C., Schlemmer, A., Tarp, U. & Hetland, M. L., 2013, In : Annals of the Rheumatic Diseases. 72, 1, p. 79-82 4 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  56. Published

    Serious Adverse Events Associated With Using Biological Agents To Treat Rheumatic Diseases: Network Meta-Analysis From a National Guideline Panel.

    Tarp, S., Tarp, U., Andersen, L. S., Lorenzen, T., Lindegaard, H. M., Stoltenberg, M., Jensen, H. S., Brock, B., Munk Mikkelsen, C., Jensen, D. V., Asmussen, K., Herlin, T. & Christensen, R. D. K., 2013. 1 p.

    Research output: Contribution to conferenceConference abstract for conferenceResearch

  57. 2012
  58. Published

    Clinical response, drug survival and predictors thereof among 548 switchers of tumor necrosis factor alpha inhibitor therapy in psoriatic arthritis. Results from the Danish nationwide Danbio Registry.

    Glintborg, B., Østergaard, M., Krogh, N. S., Andersen, M. D., Tarp, U., Loft, A. G., Lindegaard, H. M., Holland-Fischer, M., Nordin, H., Jensen, D. V. & Hetland, M. L., 2012, In : Arthritis & Rheumatism. 64, 10 suppl., p. S1081 1 p.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

Previous 1 2 Next

ID: 45069061